Cleared Traditional

K191728 - ULTepap Expiratory Positive Airway Pressure (EPAP) Device (FDA 510(k) Clearance)

Feb 2020
Decision
239d
Days
Class 2
Risk

K191728 is an FDA 510(k) clearance for the ULTepap Expiratory Positive Airway Pressure (EPAP) Device. This device is classified as a Expiratory Resistance Valve, Intranasal, For Obstructive Sleep Apnea (Class II - Special Controls, product code OHP).

Submitted by Bryggs Medical, LLC (Avon, US). The FDA issued a Cleared decision on February 21, 2020, 239 days after receiving the submission on June 27, 2019.

This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 872.5570. Intranasal Device That Creates Expiratory Resistance For The Treatment Of Obstructive Sleep Apnea..

Submission Details

510(k) Number K191728 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 27, 2019
Decision Date February 21, 2020
Days to Decision 239 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF

Device Classification

Product Code OHP - Expiratory Resistance Valve, Intranasal, For Obstructive Sleep Apnea
Device Class Class II - Special Controls
CFR Regulation 21 CFR 872.5570
Definition Intranasal Device That Creates Expiratory Resistance For The Treatment Of Obstructive Sleep Apnea.